Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 18,785 | 28,067 | 25,421 | 23,941 | 15,108 |
| Cost of Goods | 6,807 | 10,146 | 8,988 | 8,155 | 4,451 |
| Gross Profit | 11,978 | 17,921 | 16,433 | 15,786 | 10,657 |
| Operating Expenses | 11,437 | 18,156 | 34,064 | 17,159 | 10,566 |
| Operating Income | 1,348 | -89 | -16,643 | -1,218 | 542 |
| Other Income | 2,014 | 792 | 931 | 784 | -73 |
| Pre-tax Income | 3,362 | 703 | -15,712 | -434 | 469 |
| Income Tax | -173 | 82 | 126 | 14 | 24 |
| Net Income Continuous | 3,535 | 621 | -15,838 | -448 | 445 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 12,014 |
| Net Income | $11,070 | $621 | $-15,838 | $-448 | $12,459 |
| EPS Basic Total Ops | 0.24 | 0.01 | -0.33 | -0.01 | 0.27 |
| EPS Basic Continuous Ops | 0.08 | 0.01 | -0.33 | -0.01 | 0.01 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.26 |
| EPS Diluted Total Ops | 0.23 | 0.01 | -0.33 | -0.01 | 0.27 |
| EPS Diluted Continuous Ops | 0.08 | 0.01 | -0.33 | -0.01 | 0.01 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.26 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.04 | 0.00 | 0.04 | -0.01 |
| EBITDA(a) | $1,934 | $1,246 | $-15,261 | $166 | $2,246 |